HIGHLIGHTS
- who: Prostate Cancer et al. from the Urology, University of Miami, Miami, USA, Dalhousie University, Halifax, CAN, ., Montefiore have published the article: Received 11/11/2022 Review began 11/14/2022 Review ended 12/14/2022 Published 12/19/2022, in the Journal: (JOURNAL) of December/19,/2022
- what: At the five-year follow-up after ADT cessation, most patients failed to recover to their mean baseline and eugonadal T levels.
- future: Future studies on T recovery profiles following ADT cessation should include further analysis of T levels amongst varying ADT treatment regimen . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.